We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Oravax

News List

Oravax Medical to test triple antigen oral vaccine against Omicron Pharmaceutical-Technology
December 03, 2021
Indian biotechnology firm Premas Biotech’s joint venture company Oravax Medical is set to begin testing their triple antigen oral vaccine candidate against the new Omicron variant of concern.
Oravax to Present Keynote Talk on Oral COVID-19 Vaccine at the Arena International Vaccines Virtual Conference 2021 prnewswire
August 06, 2021
Oramed Pharmaceuticals Inc. today announced that its majority-owned company Oravax Medical Inc.'s oral COVID-19 vaccine will be featured in the Keynote Talk at the Arena International Vaccines Virtual Conference 2021
Premas Biotech, Oramed announce single-dose oral COVID-19 vaccine candidate expresspharma
March 22, 2021
Premas Biotech announced the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals.